{"id":"NCT02906917","sponsor":"Novo Nordisk A/S","briefTitle":"A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification","officialTitle":"This Trial is Conducted Globally. The Aim of This Trial is to Compare the Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-09-20","primaryCompletion":"2017-08-31","completion":"2017-12-24","firstPosted":"2016-09-20","resultsPosted":"2018-09-28","lastUpdate":"2019-11-13"},"enrollment":532,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Insulin degludec/insulin aspart","otherNames":[]},{"type":"DRUG","name":"Insulin glargine","otherNames":[]},{"type":"DRUG","name":"Insulin aspart","otherNames":[]}],"arms":[{"label":"IDegAsp","type":"EXPERIMENTAL"},{"label":"IGlar + IAsp","type":"ACTIVE_COMPARATOR"}],"summary":"Trial comparing effect and safety of insulin degludec/insulin aspart vs. insulin glargine plus insulin aspart in subjects with type 2 diabetes treated with basal insulin with or without oral antidiabetic treatment in need of treatment intensification.","primaryOutcome":{"measure":"Change in HbA1c (%) - Week 26","timeFrame":"Week 0, week 26","effectByArm":[{"arm":"Insulin Degludec/Insulin Aspart","deltaMin":8.2,"sd":0.8},{"arm":"Insulin Glargine + Insulin Aspart","deltaMin":8.1,"sd":0.7}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":10},"locations":{"siteCount":71,"countries":["United States","Algeria","Czechia","India","Russia","Serbia","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":["30448451","35044568"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":18,"n":265},"commonTop":["Nasopharyngitis","Headache","Upper respiratory tract infection","Back pain"]}}